The FDA’s Office of Women’s Health announced that it will be holding a conference on November 19 to discuss the differences that cannabinoids have depending on sex and gender. The scientific conference will be held virtually and registration is already available on the FDA’s site.
The agency will use this meeting to discuss the differences in how people are affected by CBD and other cannabinoids depending on their sex or gender. The FDA will look at both the biological factors in terms of the person’s sex and psychological differences in terms of the person’s gender.
Researchers, educators, clinicians, and patients are encouraged to attend. The conference will have presentations that address these issues from the perspective of health care providers, using CBD during pregnancy, and other agency views brought about by the current research being done.
The hope of this conference is to inform people more about cannabinoids as researchers continue to gather scientific evidence about these once outlawed substances. They seek to answer questions brought up by the community regarding the science, safety, and quality of CBD products on the market.
With many of the issues that CBD is most lauded to help potentially treat being present in women more often than men, the agency feels a need to address these issues as part of its efforts to keep the public informed.
The exact speakers and topics for the event are still waiting to be released.